Amedisys Inc (AMED)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 86,216 134,642 143,602 32,141 39,623 51,761 48,634 151,221 160,244 165,791 186,947 255,756 280,231 295,388 301,621 237,634 210,819 188,146 170,181 169,351
Revenue (ttm) US$ in thousands 2,348,324 2,321,060 2,289,626 2,251,407 2,236,382 2,227,658 2,229,409 2,234,331 2,223,199 2,220,452 2,215,949 2,222,225 2,214,112 2,205,500 2,196,085 2,116,978 2,071,519 2,021,492 1,972,053 1,979,978
Pretax margin 3.67% 5.80% 6.27% 1.43% 1.77% 2.32% 2.18% 6.77% 7.21% 7.47% 8.44% 11.51% 12.66% 13.39% 13.73% 11.23% 10.18% 9.31% 8.63% 8.55%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $86,216K ÷ $2,348,324K
= 3.67%

The pretax margin of Amedisys Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The pretax margin started at 8.55% on March 31, 2020, and experienced an overall upward trend, reaching its peak at 13.73% on June 30, 2021. However, in the following quarters, the pretax margin experienced a decline, dropping to 1.43% by March 31, 2024.

The trend then reversed, showing an increase to 6.27% on June 30, 2024, before dropping again to 3.67% by December 31, 2024. This fluctuation in pretax margin could indicate changes in the company's profitability before accounting for taxes, potentially driven by factors such as changes in revenue, operating expenses, or other income sources. It would be important for stakeholders to further analyze the reasons behind these fluctuations to understand the company's financial performance and sustainability.